|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Seroprevalence of leptospirosis in human was 27.84% (95% CI: 13.22-22.47) and 19.71% (95% CI: 6.78-32.65%) based on ELISA and MAT, respectively.
|
31698052 |
2020 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Comparison of the ELISA assay with MAT for the detection of Leptospiral antibodies showed a positive correlation (r value 0.345, p < 0.05), and signified the diagnostic efficacy of rPI-PLC for the definitive diagnosis of the Leptospirosis.
|
30848449 |
2019 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study verified the main Leptospira spp. serovars detected by MAT from serum of patients with suspicion of leptospirosis from 2008 to 2012 in Minas Gerais State.
|
28365095 |
2018 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Two horses were positive on urine PCR for leptospirosis (shedding prevalence 1%), yet only one had a high reciprocal MAT titer of ≥ 800.
|
30372498 |
2018 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Seroepidemiology of leptospirosis in Guilan province, northern Iran: comparison between MAT and IgM-ELISA techniques.
|
31825912 |
2018 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We showed that leptospirosis significantly affects humans in Vanuatu: 12 cases were confirmed by real-time PCR on acute blood samples (n = 5) or by high serology titers evidencing a recent infection (MAT titer ≥800 or ELISA≥18 Units, n = 7).
|
29864127 |
2018 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Serums were screened by ELISA at Institut Pasteur de Côte d'Ivoire and confirmed by MAT in the National Reference Centre for leptospirosis in Institut Pasteur in Paris.
|
30128667 |
2018 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients were confirmed as leptospirosis (n = 65) and non-leptospirosis (n = 30) by the Patoc - MAT.
|
27707560 |
2016 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
ELISA using Hap1/lipL 32-derived synthetic peptide PP is an earlier serological diagnosis of human leptospirosis than MAT.
|
19307019 |
2010 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our cLigA based-serology has a high potential for early diagnosis of leptospirosis especially when the culture and MAT results are not yet available.
|
18079011 |
2008 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Isolation was rare from humans (2/45 Leptospira isolates from 881 febrile patients sampled), but high titers of MAT antibodies against "Leptospira licerasiae" serovar Varillal were common (30%) among patients fulfilling serological criteria for acute leptospirosis in the Iquitos region, and uncommon (7%) elsewhere in Peru.
|
18382606 |
2008 |
|
Leptospirosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The methods in hand for diagnosis of leptospirosis like culture, ELISA and MAT only help to confirm the disease, and are of little value in early detection.
|
15928441 |
2005 |